iCeutica Inc.
12 articles about iCeutica Inc.
-
iCeutica Inc. Receives Key Patent For Solumatrix Fine Particle Technology™ Platform
9/23/2014
-
First Therapeutic Using iCeutica Inc.'s SoluMatrix Technology Receives FDA Approval
10/21/2013
-
iCeutica Inc. Appoints Jyrki Mattila, M.D., as Chief Business Officer
10/16/2013
-
iCeutica Inc. Announces Positive Top-line Phase 1 Results for ICE 1201 Metaxalone Program
9/12/2013
-
iCeutica Inc. Commences Clinical Program for Metaxalone SoluMatrix
11/30/2012
-
Iroko Pharmaceuticals Acquires iCeutica Inc. to Bolster Capabilities in Novel Low-Dose NSAIDs
4/28/2011
-
iCeutica Inc. Announces Sale to Partner Iroko Pharmaceuticals; 10X Uplift on Original Value
4/28/2011
-
iCeutica Inc. Completes First Reformulation Agreement with 'Big Pharma'
5/13/2009
-
iCeutica Inc. Completes GMP Scale-Up for its Nano-Sized Products
6/19/2008
-
Dr. William Bosch, a Nano-pharmaceuticals Industry Leader, Joins iCeutica Inc.
9/12/2007
-
Iroko Pharmaceuticals Acquires Nano-Reformulated Products from iCeutica Inc.
6/29/2007
-
iCeutica Inc. and Nordic Biotech Sign an Agreement to Reformulate and Commercialise Nano-Compounds Using iCeutica Inc.'s EON(TM) Platform
5/9/2007